May 14, 2025

Semaglutide at Half Dose—Same Effect?

“When care is designed around the patient, lower doses often prove sufficient."

Reuters

May 13, 2025

GLP-1s May Protect Against Obesity-Related Cancer

First-generation GLP-1 receptor agonists provide comparable protection against obesity-related cancers as bariatric surgery.

Conexiant

May 12, 2025

Delayed Puberty: Diabetes Risk Signal?

"Our results are surprising as delayed puberty is generally considered a benign condition."

Conexiant

May 12, 2025

Prenatal Cannabis Use Tied to Adverse Birth Outcomes

Researchers report that prenatal cannabis use is associated with increased risks of low birth weight, preterm birth, and small for gestational age.

Conexiant

May 12, 2025

CKD Identifying Facemasks Present Advancement

With proper expansion of the sensor array, "sensitized facemasks might be applied to the diagnosis of a larger spectrum of diseases and conditions."

Conexiant

May 08, 2025

SGLT2 Inhibitors Lower Hyperkalemia Risk in Patients Taking RAASi 

Researchers found that starting SGLT2 inhibitors in older patients on RAAS inhibitors reduced the risk of hyperkalemia and helped more patients stay on RAAS therapy.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 07, 2025

FDA Approves Low-Dose Chlorthalidone Tablet

The FDA has approved HemiClor, a 12.5-mg chlorthalidone tablet, providing patients with a low-dose option.

Conexiant

May 07, 2025

Electric Pulse Procedure May Improve T2D

A minimally invasive procedure using electrical pulses in the small intestine shows promise in significantly improving type 2 diabetes, with benefits rivaling gastric bypass surgery.

Reuters